跳至主要内容
临床试验/JPRN-UMIN000002180
JPRN-UMIN000002180已完成2 期

Phase II study of Docetaxel and CDDP and 5-FU for metastatic esophageal cancer - OGSG 0403

OGSG0 个研究点目标入组 45 人开始时间: 2009年7月10日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) severe disorders in the other organs (cardiac disorder, pulmonary fibrosis or interstitial pneumonia, liver dysfunction) 2) brain metastasis with symptoms 3) edema which needs treatment 4) severe infectious disease 5) with high fever upper than 38 0C 6) with active double cancer 7) women under pregnancy and/or nursing or women who expects pregnancy 8) with a history of severe allergic reaction against medicines 9) uncontrolled cavity fluid in the chest, abdomen or heart 10) doctor's decision not to register to this regimen

研究者

发起方
OGSG

相似试验